Papanikolaou

New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access

Retrieved on: 
Wednesday, January 10, 2024
Ageing, Woman, World Health Organization, Patient, Privacy, Health, Health equity, Knowledge, Embarrassment, Cancer, BDX, Risk, Cervical cancer, Food, Papanikolaou, The Harris Poll, HPV, Infection, American Cancer Society, Birth control

FRANKLIN LAKES, N.J., Jan. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a Harris Poll survey of women in the U.S., U.K. and Sweden, which shines a spotlight on the differences in access to cervical cancer screening and prevention.

Key Points: 
  • Self-collection for cervical cancer screening is a viable option for increasing access and health equity.
  • (In the U.S., the American Cancer Society recommends HPV primary screening for cervical cancer every five years for women aged 25-65.)
  • The results showed that most women consider cervical cancer screening a critical part of their health management (86% Sweden, 81% U.K., 76% U.S.).
  • More knowledge about high-risk HPV types and cervical cancer screening can empower people with a cervix to take greater control of their own health."

No Sleep Beverage Launches With Five Alcohol Beverage Brands

Retrieved on: 
Thursday, December 14, 2023
Retail, Restaurant, Bar, Convenience Store, Wine & Spirits, Ideation, Papanikolaou, Growth, Pernod Ricard, Castle Brands, Creativity, No Sleep, Caledonia Spirits, Bottled water, Boilermaker, Hotel

We’re bringing the best resources from both sides by providing many of the services that large companies offer while maintaining the creativity and agility of entrepreneurial ventures.”

Key Points: 
  • We’re bringing the best resources from both sides by providing many of the services that large companies offer while maintaining the creativity and agility of entrepreneurial ventures.”
    No Sleep Beverage partners with alcohol beverage brands to take their visions from early-stage to high-growth.
  • Since its fundraising close in April 2023, No Sleep Beverage has invested in and partnered with five brands: Barr Hill Gin, Solento Tequila, Nine Banded Whiskey, Juliet Wine, Soley Beverage.
  • This sentiment reflects No Sleep Beverage's commitment to providing holistic support for alcohol beverage brands to help ensure sustained growth in an increasingly complex and competitive industry.
  • Over the next 12 months, No Sleep Beverage will raise capital to pursue six to eight more transactions supporting emerging alcohol beverage brands.

5 Student Teams' Innovations Win 2023 Collegiate Inventors Competition

Retrieved on: 
Wednesday, October 25, 2023
Rhea, National Inventors Hall of Fame, Cervical cancer, United States Patent and Trademark Office, Health, National Collegiate Inventors and Innovators Alliance, Arrow Electronics, CRISPR, Invention, Rupture, Nucleotide, Montreal, Pap test, Papanikolaou, Cell, Research, Death, Achilles tendon rupture, Tissue, Aneurysm, DSM-IV codes, University, Diagnosis, Student, Surgeon, 2007 College Football Hall of Fame inductees, Probability, Privacy, Safety, Cancer, People's Choice Awards, Patient, PAP, Biomedical engineering, OLV, Patent, Birth control, Medical imaging, Fame

"The Collegiate Inventors Competition showcases the next generation of game changers — young inventors who demonstrate an innovative mindset that empowers them to solve the world's greatest challenges," said National Inventors Hall of Fame CEO Michael Oister.

Key Points: 
  • "The Collegiate Inventors Competition showcases the next generation of game changers — young inventors who demonstrate an innovative mindset that empowers them to solve the world's greatest challenges," said National Inventors Hall of Fame CEO Michael Oister.
  • "These student teams earned the opportunity this week to meet and learn directly from our nation's greatest innovators — the Inductees of the National Inventors Hall of Fame."
  • Established in 1990, the Collegiate Inventors Competition is a program of the National Inventors Hall of Fame and is sponsored by the USPTO, Arrow Electronics (sponsor of the Arrow Electronics People's Choice Award), and Honda.
  • FADpad is an at-home menstrual blood screening tool that allows users to collect their personal health information safely, comfortably and privately.

AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product

Retrieved on: 
Monday, October 9, 2023
Diagnosis, Papanikolaou, PAP, AI, Cell, Cancer, Artificial intelligence, CE, Gynaecology, Cervical cancer, LBC, Obstetrics, Woman, Blood, Medical device, Typhoon Noul (2015)

YONGIN, South Korea, Oct. 9, 2023 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an Artificial Intelligence (AI) based blood and cancer diagnostic platform company, has newly introduced 'miLab™ Cartridge CER', a cervical cell analysis product at the International Federation of Gynecology and Obstetrics 2023.

Key Points: 
  • YONGIN, South Korea, Oct. 9, 2023 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an Artificial Intelligence (AI) based blood and cancer diagnostic platform company, has newly introduced 'miLab™ Cartridge CER', a cervical cell analysis product at the International Federation of Gynecology and Obstetrics 2023.
  • When used with miLab™, Noul's AI-based diagnostic platform, it provides staining, imaging, and cell analysis results that assist user's decision making.
  • David Lim, CEO of Noul, said, "Through the launch of cervical cell analysis products, we have made a real step forward in the cancer diagnostic business.
  • We want to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women."

2023 Collegiate Inventors Competition Finalists Show Future of American Innovation

Retrieved on: 
Thursday, September 21, 2023
Rhea, Failure, Intellectual property, Privacy, Hospital, Patient, Risk, United States Patent and Trademark Office, Health, Nanotechnology, Collegiate, Commerce, Tissue, Arrow Electronics, Patent, Human, OLV, Lipopolysaccharide, Immunity, Research, Biomedical engineering, Invention, Death, Montreal, FLASH, Cervical cancer, Diagnosis, Aneurysm, Game Developers Choice Awards, Pap test, Skin, Safety, Vaccine, Poultry, Cancer, National Collegiate Inventors and Innovators Alliance, Under Secretary of Commerce for Intellectual Property, Cell, DSM-IV codes, Rupture, Water, Papanikolaou, National Inventors Hall of Fame, CRISPR, Surgeon, Probability, PAP, Infection, Achilles tendon rupture, Septic shock, Pain, Student, Nucleotide, Farm, Management, Birth control, Medical imaging

NORTH CANTON, Ohio, Sept. 21, 2023 /PRNewswire/ -- The Collegiate Inventors Competition® , an annual competition that has rewarded innovations, discoveries and research by college and university students and their faculty advisers for more than 30 years, announced today its 2023 finalists.

Key Points: 
  • NORTH CANTON, Ohio, Sept. 21, 2023 /PRNewswire/ -- The Collegiate Inventors Competition® , an annual competition that has rewarded innovations, discoveries and research by college and university students and their faculty advisers for more than 30 years, announced today its 2023 finalists.
  • This year's finalists and their inventions provide a glimpse into the future of American innovation and emerging technological trends — from providing immunity from avian influenza to hunger-regulating hormone modulation.
  • "The USPTO is proud to host the 2023 Collegiate Inventors Competition — a program where the brightest college minds will showcase inventions that will shape the future of American innovation," said Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director of the USPTO.
  • Established in 1990, the Collegiate Inventors Competition is a program of the National Inventors Hall of Fame and is sponsored by the USPTO, Arrow Electronics (Arrow Electronics People's Choice Award), and Honda.

HKG Epitherapeutics Publishes New Data on epiCervix Test, Showing Ability to Detect Cervical Cancer Earlier than Traditional Screening Methods

Retrieved on: 
Tuesday, August 22, 2023
Survival rate, DNA, Tooth, Anxiety, PAP, Survival, DPP10, Cancer, Ageing, Cervical cancer, Woman, CA10, International Journal of Cancer, Cell, Death, Professor, The Company, Patient, Rated R, Canadian International Council, McGill University, HPV, DNA methylation, Principal, Gene, HAS1, Birth control, Papanikolaou, HKG

HONG KONG, Aug. 22, 2023 /PRNewswire/ -- HKG Epitherapeutics ("HKG" or the "Company"), a commercial-stage biotech company developing novel tools for the early detection of cancer and promoting healthy aging, in collaboration with McGill University, announced today that the International Journal of Cancer has published new data on the ability of the Company's proprietary epiCervix test to detect cervical cancer in patients sooner compared to traditional screening methods, including manual laboratory cell examination from Papanicolaou (Pap) smears and human papillomavirus (HPV) testing.

Key Points: 
  • As cervical cancer remains the fourth most common type of cancer among women globally , the World Health Organization calls for women to be screened regularly with a high-performance test.
  • In 2020 alone, there were approximately 604,000 new cases and 342,000 deaths due to cervical cancer.
  • Through integrating epiCervix into the current screening process, we can make cervical cancer no different for women than needing to get a tooth extracted."
  • HKG's epiCervix test can detect cervical cancer at its earliest stages by looking at changes in four specific genes.

Pap Test Market is expected to display a steady growth of 11.4% due to the rise in the number of disease-causing HPV cases| UnivDatos Market Insights

Retrieved on: 
Friday, March 17, 2023
Papanikolaou, COVID-19, QIAGEN, Probability, PAP, Liquid-based cytology, Hospital, Infection, Cervical cancer, Shock, Woman, Research, Cell, Inflammation, Pap test, Vaginal cancer, Thermo Fisher Scientific, Laboratory, Automation, Cancer, HPV, Clifton Springs Hospital & Clinic, Diagnosis, Mortality, American Cancer Society, AI, PCR, Female, BD, Disease, Birth control, Pharmaceutical industry, NOIDA, Others

The pap test market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The pap test market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the pap test market.
  • The pap test market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the pap test market at the global and regional levels.

Pap Test Market is expected to display a steady growth of 11.4% due to the rise in the number of disease-causing HPV cases| UnivDatos Market Insights

Retrieved on: 
Friday, March 17, 2023
Papanikolaou, COVID-19, QIAGEN, Probability, PAP, Liquid-based cytology, Hospital, Infection, Cervical cancer, Shock, Woman, Research, Cell, Inflammation, Pap test, Vaginal cancer, Thermo Fisher Scientific, Laboratory, Automation, Cancer, HPV, Clifton Springs Hospital & Clinic, Diagnosis, Mortality, American Cancer Society, AI, PCR, Female, BD, Disease, Birth control, Pharmaceutical industry, NOIDA, Others

The pap test market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The pap test market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the pap test market.
  • The pap test market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the pap test market at the global and regional levels.

Global HPV Testing and PAP Test Market 2022: Need for Novel, Technologically Advanced, and Cost-Effective HPV and PAP Screening Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, September 9, 2022
Infectious Diseases, General Health, Health, COVID-19, Wart, PAP, HPV, Coronavirus, Penis, Head, Papilloma, Cervical cancer, DNA, Pharynx, Vulva, Prevalence, STI, CAGR, Adult, Non-governmental organization, Pharmaceutical industry, Vaccine, Papanikolaou, Growth

The "HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global HPV testing and PAP test market reached a value of US$ 3.73 Billion in 2021.
  • HPV Testing and PAP Test Market Trends:
    The increasing prevalence of cervical cancer, especially amongst the adult demographics.
  • due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth.